Loading…
Protective Effect of Sulforaphane against Dopaminergic Cell Death
Parkinson's disease (PD) is a progressive neurodegenerative disorder with a selective loss of dopaminergic neurons in the substantia nigra. Evidence suggests oxidation of dopamine (DA) to DA quinone and consequent oxidative stress as a major factor contributing to this vulnerability. We have pr...
Saved in:
Published in: | The Journal of pharmacology and experimental therapeutics 2007-04, Vol.321 (1), p.249-256 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3 |
container_end_page | 256 |
container_issue | 1 |
container_start_page | 249 |
container_title | The Journal of pharmacology and experimental therapeutics |
container_volume | 321 |
creator | Han, Ji Man Lee, Yong Jin Lee, So Yeon Kim, Eun Mee Moon, Younghye Kim, Ha Won Hwang, Onyou |
description | Parkinson's disease (PD) is a progressive neurodegenerative disorder with a selective loss of dopaminergic neurons in the
substantia nigra. Evidence suggests oxidation of dopamine (DA) to DA quinone and consequent oxidative stress as a major factor
contributing to this vulnerability. We have previously observed that exposure to or induction of NAD(P)H:quinone reductase
(QR1), the enzyme that catalyzes the reduction of quinone, effectively protects DA cells. Sulforaphane (SF) is a drug identified
as a potent inducer of QR1 in various non-neuronal cells. In the present study, we show that SF protects against compounds
known to induce DA quinone production (6-hydroxydopamine and tetrahydrobiopterin) in DAergic cell lines CATH.a and SK-N-BE(2)C
as well as in mesencephalic DAergic neurons. SF leads to attenuation of the increase in protein-bound quinone in tetrahydrobiopterin-treated
cells, but this does not occur in cells that have been depleted of DA, suggesting involvement of DA quinone. SF pretreatment
prevents membrane damage, DNA fragmentation, and accumulation of reactive oxygen species. SF causes increases in mRNA levels
and enzymatic activity of QR1 in a dose-dependent manner. Taken together, these results indicate that SF causes induction
of QR1 gene expression, removal of intracellular DA quinone, and protection against toxicity in DAergic cells. Thus, this
major isothiocyanate found in cruciferous vegetables may serve as a potential candidate for development of treatment and/or
prevention of PD. |
doi_str_mv | 10.1124/jpet.106.110866 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1124_jpet_106_110866</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17259450</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3</originalsourceid><addsrcrecordid>eNpFkM1Lw0AQxRdRbK2evUlO3mJndpNtcixt_YCCgnpe9jNJSbphkyr9701JwdPMG35v4D1C7hGeEGky37W2f0Lgg4KM8wsyxZRiDAjskkwBKI1ZytMJuem6HQAmCWfXZIILmuZJClOy_Ai-t7qvfmy0cW7YIu-iz0PtfJBtKfc2koWs9l0frX0rm2pvQ1HpaGXrOlpb2Ze35MrJurN35zkj38-br9VrvH1_eVstt7FmOe1jTTPIEpkxJR23CJonxjC0ariYBULKLc-oyQ1Vucul0kaj4QhKZRlQptiMzMe_OviuC9aJNlSNDEeBIE5liFMZg-BiLGNwPIyO9qAaa_75c_oBeByBsirK3ypYMSQOjdS-9sVRMIoCBU1y9gc4V2iM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Protective Effect of Sulforaphane against Dopaminergic Cell Death</title><source>Freely Accessible Journals</source><creator>Han, Ji Man ; Lee, Yong Jin ; Lee, So Yeon ; Kim, Eun Mee ; Moon, Younghye ; Kim, Ha Won ; Hwang, Onyou</creator><creatorcontrib>Han, Ji Man ; Lee, Yong Jin ; Lee, So Yeon ; Kim, Eun Mee ; Moon, Younghye ; Kim, Ha Won ; Hwang, Onyou</creatorcontrib><description>Parkinson's disease (PD) is a progressive neurodegenerative disorder with a selective loss of dopaminergic neurons in the
substantia nigra. Evidence suggests oxidation of dopamine (DA) to DA quinone and consequent oxidative stress as a major factor
contributing to this vulnerability. We have previously observed that exposure to or induction of NAD(P)H:quinone reductase
(QR1), the enzyme that catalyzes the reduction of quinone, effectively protects DA cells. Sulforaphane (SF) is a drug identified
as a potent inducer of QR1 in various non-neuronal cells. In the present study, we show that SF protects against compounds
known to induce DA quinone production (6-hydroxydopamine and tetrahydrobiopterin) in DAergic cell lines CATH.a and SK-N-BE(2)C
as well as in mesencephalic DAergic neurons. SF leads to attenuation of the increase in protein-bound quinone in tetrahydrobiopterin-treated
cells, but this does not occur in cells that have been depleted of DA, suggesting involvement of DA quinone. SF pretreatment
prevents membrane damage, DNA fragmentation, and accumulation of reactive oxygen species. SF causes increases in mRNA levels
and enzymatic activity of QR1 in a dose-dependent manner. Taken together, these results indicate that SF causes induction
of QR1 gene expression, removal of intracellular DA quinone, and protection against toxicity in DAergic cells. Thus, this
major isothiocyanate found in cruciferous vegetables may serve as a potential candidate for development of treatment and/or
prevention of PD.</description><identifier>ISSN: 0022-3565</identifier><identifier>EISSN: 1521-0103</identifier><identifier>DOI: 10.1124/jpet.106.110866</identifier><identifier>PMID: 17259450</identifier><language>eng</language><publisher>United States: American Society for Pharmacology and Experimental Therapeutics</publisher><subject>Biopterins - analogs & derivatives ; Biopterins - antagonists & inhibitors ; Biopterins - pharmacology ; Cell Death - drug effects ; Cell Membrane - drug effects ; Cell Membrane - ultrastructure ; Cells, Cultured ; Chromosomes - drug effects ; DNA Fragmentation - drug effects ; Dopamine - physiology ; Humans ; Immunohistochemistry ; Isothiocyanates ; L-Lactate Dehydrogenase - metabolism ; Oxidopamine - pharmacology ; Quinones - pharmacology ; Reactive Oxygen Species - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Sulfoxides ; Thiocyanates - pharmacology</subject><ispartof>The Journal of pharmacology and experimental therapeutics, 2007-04, Vol.321 (1), p.249-256</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3</citedby><cites>FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17259450$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Han, Ji Man</creatorcontrib><creatorcontrib>Lee, Yong Jin</creatorcontrib><creatorcontrib>Lee, So Yeon</creatorcontrib><creatorcontrib>Kim, Eun Mee</creatorcontrib><creatorcontrib>Moon, Younghye</creatorcontrib><creatorcontrib>Kim, Ha Won</creatorcontrib><creatorcontrib>Hwang, Onyou</creatorcontrib><title>Protective Effect of Sulforaphane against Dopaminergic Cell Death</title><title>The Journal of pharmacology and experimental therapeutics</title><addtitle>J Pharmacol Exp Ther</addtitle><description>Parkinson's disease (PD) is a progressive neurodegenerative disorder with a selective loss of dopaminergic neurons in the
substantia nigra. Evidence suggests oxidation of dopamine (DA) to DA quinone and consequent oxidative stress as a major factor
contributing to this vulnerability. We have previously observed that exposure to or induction of NAD(P)H:quinone reductase
(QR1), the enzyme that catalyzes the reduction of quinone, effectively protects DA cells. Sulforaphane (SF) is a drug identified
as a potent inducer of QR1 in various non-neuronal cells. In the present study, we show that SF protects against compounds
known to induce DA quinone production (6-hydroxydopamine and tetrahydrobiopterin) in DAergic cell lines CATH.a and SK-N-BE(2)C
as well as in mesencephalic DAergic neurons. SF leads to attenuation of the increase in protein-bound quinone in tetrahydrobiopterin-treated
cells, but this does not occur in cells that have been depleted of DA, suggesting involvement of DA quinone. SF pretreatment
prevents membrane damage, DNA fragmentation, and accumulation of reactive oxygen species. SF causes increases in mRNA levels
and enzymatic activity of QR1 in a dose-dependent manner. Taken together, these results indicate that SF causes induction
of QR1 gene expression, removal of intracellular DA quinone, and protection against toxicity in DAergic cells. Thus, this
major isothiocyanate found in cruciferous vegetables may serve as a potential candidate for development of treatment and/or
prevention of PD.</description><subject>Biopterins - analogs & derivatives</subject><subject>Biopterins - antagonists & inhibitors</subject><subject>Biopterins - pharmacology</subject><subject>Cell Death - drug effects</subject><subject>Cell Membrane - drug effects</subject><subject>Cell Membrane - ultrastructure</subject><subject>Cells, Cultured</subject><subject>Chromosomes - drug effects</subject><subject>DNA Fragmentation - drug effects</subject><subject>Dopamine - physiology</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Isothiocyanates</subject><subject>L-Lactate Dehydrogenase - metabolism</subject><subject>Oxidopamine - pharmacology</subject><subject>Quinones - pharmacology</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Sulfoxides</subject><subject>Thiocyanates - pharmacology</subject><issn>0022-3565</issn><issn>1521-0103</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNpFkM1Lw0AQxRdRbK2evUlO3mJndpNtcixt_YCCgnpe9jNJSbphkyr9701JwdPMG35v4D1C7hGeEGky37W2f0Lgg4KM8wsyxZRiDAjskkwBKI1ZytMJuem6HQAmCWfXZIILmuZJClOy_Ai-t7qvfmy0cW7YIu-iz0PtfJBtKfc2koWs9l0frX0rm2pvQ1HpaGXrOlpb2Ze35MrJurN35zkj38-br9VrvH1_eVstt7FmOe1jTTPIEpkxJR23CJonxjC0ariYBULKLc-oyQ1Vucul0kaj4QhKZRlQptiMzMe_OviuC9aJNlSNDEeBIE5liFMZg-BiLGNwPIyO9qAaa_75c_oBeByBsirK3ypYMSQOjdS-9sVRMIoCBU1y9gc4V2iM</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Han, Ji Man</creator><creator>Lee, Yong Jin</creator><creator>Lee, So Yeon</creator><creator>Kim, Eun Mee</creator><creator>Moon, Younghye</creator><creator>Kim, Ha Won</creator><creator>Hwang, Onyou</creator><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20070401</creationdate><title>Protective Effect of Sulforaphane against Dopaminergic Cell Death</title><author>Han, Ji Man ; Lee, Yong Jin ; Lee, So Yeon ; Kim, Eun Mee ; Moon, Younghye ; Kim, Ha Won ; Hwang, Onyou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biopterins - analogs & derivatives</topic><topic>Biopterins - antagonists & inhibitors</topic><topic>Biopterins - pharmacology</topic><topic>Cell Death - drug effects</topic><topic>Cell Membrane - drug effects</topic><topic>Cell Membrane - ultrastructure</topic><topic>Cells, Cultured</topic><topic>Chromosomes - drug effects</topic><topic>DNA Fragmentation - drug effects</topic><topic>Dopamine - physiology</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Isothiocyanates</topic><topic>L-Lactate Dehydrogenase - metabolism</topic><topic>Oxidopamine - pharmacology</topic><topic>Quinones - pharmacology</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Sulfoxides</topic><topic>Thiocyanates - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Han, Ji Man</creatorcontrib><creatorcontrib>Lee, Yong Jin</creatorcontrib><creatorcontrib>Lee, So Yeon</creatorcontrib><creatorcontrib>Kim, Eun Mee</creatorcontrib><creatorcontrib>Moon, Younghye</creatorcontrib><creatorcontrib>Kim, Ha Won</creatorcontrib><creatorcontrib>Hwang, Onyou</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Han, Ji Man</au><au>Lee, Yong Jin</au><au>Lee, So Yeon</au><au>Kim, Eun Mee</au><au>Moon, Younghye</au><au>Kim, Ha Won</au><au>Hwang, Onyou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protective Effect of Sulforaphane against Dopaminergic Cell Death</atitle><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle><addtitle>J Pharmacol Exp Ther</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>321</volume><issue>1</issue><spage>249</spage><epage>256</epage><pages>249-256</pages><issn>0022-3565</issn><eissn>1521-0103</eissn><abstract>Parkinson's disease (PD) is a progressive neurodegenerative disorder with a selective loss of dopaminergic neurons in the
substantia nigra. Evidence suggests oxidation of dopamine (DA) to DA quinone and consequent oxidative stress as a major factor
contributing to this vulnerability. We have previously observed that exposure to or induction of NAD(P)H:quinone reductase
(QR1), the enzyme that catalyzes the reduction of quinone, effectively protects DA cells. Sulforaphane (SF) is a drug identified
as a potent inducer of QR1 in various non-neuronal cells. In the present study, we show that SF protects against compounds
known to induce DA quinone production (6-hydroxydopamine and tetrahydrobiopterin) in DAergic cell lines CATH.a and SK-N-BE(2)C
as well as in mesencephalic DAergic neurons. SF leads to attenuation of the increase in protein-bound quinone in tetrahydrobiopterin-treated
cells, but this does not occur in cells that have been depleted of DA, suggesting involvement of DA quinone. SF pretreatment
prevents membrane damage, DNA fragmentation, and accumulation of reactive oxygen species. SF causes increases in mRNA levels
and enzymatic activity of QR1 in a dose-dependent manner. Taken together, these results indicate that SF causes induction
of QR1 gene expression, removal of intracellular DA quinone, and protection against toxicity in DAergic cells. Thus, this
major isothiocyanate found in cruciferous vegetables may serve as a potential candidate for development of treatment and/or
prevention of PD.</abstract><cop>United States</cop><pub>American Society for Pharmacology and Experimental Therapeutics</pub><pmid>17259450</pmid><doi>10.1124/jpet.106.110866</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3565 |
ispartof | The Journal of pharmacology and experimental therapeutics, 2007-04, Vol.321 (1), p.249-256 |
issn | 0022-3565 1521-0103 |
language | eng |
recordid | cdi_crossref_primary_10_1124_jpet_106_110866 |
source | Freely Accessible Journals |
subjects | Biopterins - analogs & derivatives Biopterins - antagonists & inhibitors Biopterins - pharmacology Cell Death - drug effects Cell Membrane - drug effects Cell Membrane - ultrastructure Cells, Cultured Chromosomes - drug effects DNA Fragmentation - drug effects Dopamine - physiology Humans Immunohistochemistry Isothiocyanates L-Lactate Dehydrogenase - metabolism Oxidopamine - pharmacology Quinones - pharmacology Reactive Oxygen Species - metabolism Reverse Transcriptase Polymerase Chain Reaction Sulfoxides Thiocyanates - pharmacology |
title | Protective Effect of Sulforaphane against Dopaminergic Cell Death |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A50%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protective%20Effect%20of%20Sulforaphane%20against%20Dopaminergic%20Cell%20Death&rft.jtitle=The%20Journal%20of%20pharmacology%20and%20experimental%20therapeutics&rft.au=Han,%20Ji%20Man&rft.date=2007-04-01&rft.volume=321&rft.issue=1&rft.spage=249&rft.epage=256&rft.pages=249-256&rft.issn=0022-3565&rft.eissn=1521-0103&rft_id=info:doi/10.1124/jpet.106.110866&rft_dat=%3Cpubmed_cross%3E17259450%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/17259450&rfr_iscdi=true |